While not officially approved, Eli Lilly says it could be an alternative to injectable drugs like ozempic as a once-a-day ...

Who could take the new weight-loss pill? In a nine-month trial on patients with type 2 diabetes, those on the highe ...

Last, but certainly not least, tirzepatide could become a medicinal equivalent of a Swiss army knife. It's already approved in treating diabetes, obesity, and obstructive sleep apnea. Lilly is ...

Learn how and where to inject Zepbound and where to get additional help. Plus, get tips for injecting the drug at home and ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

U.S.-listed shares of Novo Nordisk plunged 7% in intraday trading Thursday after rival Eli Lilly reported positive oral ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at ...

Zoom out: The positive results sent Lilly's stock soaring 16% Thursday to $852. Bank of America's Anderson projected 2030 ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

It's little secret that America has a weight problem. For decades, Americans have embraced and abandoned countless ...